Cargando…
Prognostic Factors of Early Stage Epithelial Ovarian Carcinoma
We aimed to determine prognostic factors of early stage (I/II) epithelial ovarian carcinoma (EOC) including clinicopathologic and chemotherapeutic regimens. Four hundred and thirty-seven women who underwent primary staging surgery with adjuvant chemotherapy between January 1, 2000 and December 31, 2...
Autores principales: | Hsieh, Shu-Feng, Lau, Hei-Yu, Wu, Hua-Hsi, Hsu, Heng-Cheng, Twu, Nae-Fang, Cheng, Wen-Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406698/ https://www.ncbi.nlm.nih.gov/pubmed/30795566 http://dx.doi.org/10.3390/ijerph16040637 |
Ejemplares similares
-
Periostin in tumor microenvironment is associated with poor prognosis and platinum resistance in epithelial ovarian carcinoma
por: Sung, Pi-Lin, et al.
Publicado: (2015) -
Outcome and prognostic factors of unexpected ovarian carcinomas
por: Cheng, Ching‐Yu, et al.
Publicado: (2022) -
Ovarian cancer risk score predicts chemo-response and outcome in epithelial ovarian carcinoma patients
por: Lu, Hsiao-Yun, et al.
Publicado: (2020) -
Survival benefit of patients with early-stage ovarian carcinoma treated with paclitaxel chemotherapeutic regimens
por: Chen, Chien-An, et al.
Publicado: (2018) -
Overexpression of CHI3L1 is associated with chemoresistance and poor outcome of epithelial ovarian carcinoma
por: Chiang, Ying-Cheng, et al.
Publicado: (2015)